Startup BioSample Solutions Nets $70K Investment for New 'Precision' Sample-Prep Method | GenomeWeb

By Ben Butkus

BioSample Solutions has received a $70,000 investment from a state economic-development agency to help it develop its new nucleic acid-extraction method for downstream amplification and clinical diagnostics, the company's founder said this week.

In addition, the Bethlehem, Pa.-based startup is collaborating with Sparton Medical Systems, the medical device division of electronics and manufacturing services firm Sparton, to automate the sample-prep method, PCR Insider has learned.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Browse our free articles
You can still register for access to our free content.

In Science this week: Neanderthal-derived DNA linked to modern ailments, and more.

Japan needs to catch up on its gene-editing research efforts, the Japan News writes.

Hundreds of people have signed an online petition calling for zero tolerance to sexual harassment in the sciences.

Jeff Huber, former Google X senior vice president, joins Grail as its CEO.